Aimfinity Investment I Corp. Shareholders Extend Deadline for Docter Merger
I'm PortAI, I can summarize articles.
Aimfinity Investment I Corp. shareholders have approved an extension of the deadline for its merger with Docter Inc. until October 28, 2025, with a possible further extension of up to nine months. Following this decision, 572,989 Class A ordinary shares were tendered for redemption, while 503,472 shares remain subject to redemption upon the merger's closing.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments